The total return over the past 12 months is +9.71% vs. +16.94% for the S&P 500. So far it's up +39.29% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +9.69% | (84.76%) | (83.91%) | N/A | N/A | N/A |
| Total Return CAGR | +9.71% | (84.76%) | (83.91%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ENDRA Life Sciences Inc. (NDRA)
| Year | Start price | End price | NDRA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.53 | $6.31 | +39.29% | +14.51% | +24.78% |
| 2025 | $6.26 | $4.53 | (27.63%) | +17.72% | (45.35%) |
| 2024 | $3,710.00 | $6.26 | (99.83%) | +24.89% | (124.72%) |
| 2023 | $7,122.50 | $3,710.00 | (47.91%) | +26.19% | (74.10%) |
| 2022 | $24,213.00 | $7,122.50 | (70.58%) | (18.17%) | (52.41%) |
| 2021 | $26,250.00 | $24,213.00 | (7.76%) | +28.74% | (36.50%) |
| 2020 | $58,800.00 | $26,250.00 | (55.36%) | +18.37% | (73.73%) |
| 2019 | $52,500.00 | $58,800.00 | +12.00% | +31.22% | (19.22%) |
| 2018 | $170,110.50 | $52,500.00 | (69.14%) | (4.56%) | (64.58%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
